User:Mr. Ibrahem/Octreotide

Octreotide, sold under the brand name Sandostatin among others, is a medication used to treat carcinoid syndrome, acromegaly, congenital hyperinsulinism, and gastrointestinal bleeding due to esophageal varices. It can be given by injection into a vein or muscle. The immediate release form may be effective up to 12 hours.

Common side effects include nausea, a slow heart rate, and abdominal discomfort. Other side effects may include low or high blood sugar, gall bladder problems, and anaphylaxis. It is unclear if use during pregnancy is safe. Use is not recommended when breastfeeding. It mimics the effects of natural somatostatin and inhibits the release of growth hormone, serotonin, insulin, and glucagon.

Octreotide was first made in 1979, by the chemist Wilfried Bauer. It is on the World Health Organization's List of Essential Medicines. It was approved for medical use in the United States in 1988. It is available as a generic medication. In the United Kingdom it costs about 3 pounds per 50 ug dose as of 2020. In the United States this amount costs about 5.30 USD as of 2020.